ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer—Reduced CK5 Expression in Metastases

Breast cancer can recur even decades after the primary therapy. Markers are needed to predict cancer progression and the risk of late recurrence. The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), proliferation marker Ki-67, and cytokeratin CK5 w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Joensuu, Kristiina, Leidenius, Marjut, Kero, Mia, Andersson, Leif C., Horwitz, Kathryn B., Heikkilä, Päivi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Libertas Academica 2013
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579427/
https://ncbi.nlm.nih.gov/pubmed/23514931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S10701
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg